Trials / Completed
CompletedNCT02766036
Propolis Effects in Patients With Chronic Kidney Disease
Propolis Effects on Proteinuria and Kidney Function in Patients With Chronic Kidney Disease
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- University of Sao Paulo General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to determine the impact of Propolis on proteinuria reduction and protection of the glomerular filtration rate in chronic renal failure patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Propolis | Patients will receive 500 mg / day of the propolis extract in the form of tablets split in two daily doses |
| DRUG | Placebo | Patients will receive 500 mg / day of the placebo in the form of tablets split in two daily doses |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2018-02-01
- Completion
- 2018-03-01
- First posted
- 2016-05-09
- Last updated
- 2018-05-03
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT02766036. Inclusion in this directory is not an endorsement.